AbbVie snaps up CAR-T startup in a $2.1B deal

Also: HHS to continue funding cancer prevention, tracking work in states after uncertainty

July 1, 2025 Check out STAT+

Sponsored By

Adobe STAT+ | HHS to continue funding cancer prevention, tracking work in states after uncertainty The funding had been in doubt, producing anxieties among local officials. Efforts could still be affected by HHS' reorganization. By Isabella Cueto STAT+ | Supreme Court rejects challenge to free preventive care, bolsters RFK Jr.'s power Supreme Court's Braidwood decision preserves free preventive health care, sets stage for potential bigger role for RFK Jr. in determining coverage. By Angus Chen STAT+ | AbbVie snaps up CAR-T company in a deal worth $2.1 billion Capstan Therapeutics approach has stirred excitement in the CAR-T field, which has stalled in recent years due to scientific and logistical hurdles. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser